Perbedaan Organon Pharma Indonesia Tbk. dan Sejahteraraya Anugrahjaya Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sejahteraraya Anugrahjaya Tbk. diperdagangkan di Rp15.600 (kapitalisasi pasar 159,11 T, volume 24 jam 10,1 rb). Perbedaan utamanya: Sejahteraraya Anugrahjaya Tbk. jauh lebih besar — sekitar 1524× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SRAJ | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 159,11 T |
Volume | — | 10,1 rb |
Lot | — | 101 |
Perputaran | — | 147,99 jt |
Harga Rata-rata | — | 14.652,23 |
Nilai Transaksi | — | 147,99 jt |
Harga Ekuilibrium Indikatif | — | 15.600 |
Volume Ekuilibrium Indikatif | — | 59 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Sejahteraraya Anugrahjaya (the Company) was established based on Notarial Deed of Misahardi SH. No. 210 dated May 20, 1991, and has been improved based on Notarial Deed. No. 200 of the same notary, dated December 11, 1992. The company commenced its operations on July 1995. The companys articles of association have been change several times, the latest was based on Extraordinary Resolution of Shareholders stated on Notarial Deed No. 145 dated June 17, 2011 of Buntario Tigris, SH regarding the increase on capital stock and issued.
Selengkapnya di halaman SRAJ →